26-Aug-15 China is aiming to control “wildly” growing stem cell therapy, issuing its first regulation covering the largely controversial medical procedure. “Only eligible hospitals can work with stem cells in clinical trials for research and there must not be fees or advertising,” said the National Health and Family Planning Commission. [image: Liu Haifeng / Xinhua Press / Corbis]

19-Aug-15 A new guideline allows foreign drugs to undergo clinical trials in their home country and in China at the same pace, speeding up approval procedures for new drugs that are badly needed in China. Clinical trials of new foreign drugs in China normally lag behind those in the home country. [image: Alamy / Daily Mail]

14-Aug-15 China's medical technology sector growth exceeds the global average, but medical technology imports are declining as foreign investors are hampered by "buy local" guidelines and murky registration criteria. Local producers are under pressure to modernise and the government is funding innovation. [image: PolyOne]

 Insights

13-Aug-15 Singapore based Asian American Medical Group is planning to develop a diagnostic and wellness centre in Zhuhai, China, to leverage on the growth of medical tourism. AAMG’s planned Zhuhai-Singapore Life Science Park will offer health screening, endoscopic and operation services, and multi-disciplinary medical consultations. The company will be fully backed by the University of Pittsburgh Medical Center. [image: Proactive Investors Australia]